Evidence map›Paper›PMID 41505485›Full record

ArticlePLOS digital health2026

Economic cost of strategic implementation approaches to increase uptake of digital therapeutics for substance use disorders in a large integrated health system.

Edwin S Wong, Caitlin N Dorsey, Tara C Beatty, Jennifer F Bobb, Kelsey Stefanik-Guizlo, Dustin L Key, Arvind Ramaprasan, Abisola E Idu, John C Fortney, Jessica Mogk and 5 more

Registry-linked trialAbstract read
In one paragraph

Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05160233 (Digital Treatments for Opioids and Other Substance Use Disorders), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05160233 nacompletednot on this map

Digital Treatments for Opioids and Other Substance Use Disorders (DIGITS) in Primary Care: A Hybrid Type-III Implementation Trial

TypeinterventionalSponsorKaiser PermanenteRan2021 to 2025Enrolled18,430ConditionsDrug Use Disorders, Illicit Drug Use, Alcohol-Related Disorders, Opioid Use DisorderArmsStandard implementation, Health Coaching, Practice Facilitation
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Edwin S WongDepartment of Health Systems and Population Health, University of Washington, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0002-6079-686X
Caitlin N DorseyKaiser Permanente Washington Health Research Institute, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0002-7044-7348
Tara C BeattyKaiser Permanente Washington Health Research Institute, Seattle, Washington, United States of America.
Jennifer F BobbKaiser Permanente Washington Health Research Institute, Seattle, Washington, United States of America.
Kelsey Stefanik-GuizloKaiser Permanente Washington Health Research Institute, Seattle, Washington, United States of America.
Dustin L KeyKaiser Permanente Washington Health Research Institute, Seattle, Washington, United States of America.
Arvind RamaprasanKaiser Permanente Washington Health Research Institute, Seattle, Washington, United States of America.
Abisola E IduKaiser Permanente Washington Health Research Institute, Seattle, Washington, United States of America.
John C FortneyCenter of Innovation for Veteran-Centered and Value-Driven Care, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, United States of America.
Jessica MogkKaiser Permanente Washington Health Research Institute, Seattle, Washington, United States of America.
Lorella PalazzoKaiser Permanente Washington Health Research Institute, Seattle, Washington, United States of America.
Ryan M CaldeiroKaiser Permanente Washington Health Research Institute, Seattle, Washington, United States of America.
Deborah KingKaiser Permanente Washington Health Research Institute, Seattle, Washington, United States of America.
Angela Garza McWethyKaiser Permanente Washington Health Research Institute, Seattle, Washington, United States of America.
Joseph E GlassDepartment of Health Systems and Population Health, University of Washington, Seattle, Washington, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence-based digital therapeutics are a promising approach for the scale-up of substance use disorder (SUD) treatments. Despite demonstrated efficacy, utilization of digital therapeutics is low. Strategic implementation approaches have potential for increasing digital therapeutic use. Applicability to health systems depends, in part, on the economic costs. The objective of this study was to describe implementation and intervention costs of implementation strategies to increase uptake of an evidence-based digital treatment for SUD. We conducted an economic evaluation alongside a hybrid type III cluster-randomized trial within a large integrated health system. All clinics implemented a standard implementation (SI) strategy, and clinics were assigned using 2x2 factorial randomization to additionally receive practice facilitation (PF) and/or health coaching (HC). Implementation costs included the cost of time devoted to implementation activities and direct operating costs. Time devoted to implementation activities was ascertained through structured meeting logs and time use surveys. Operating costs were captured using project budget reports. Intervention costs included expenses for prescriptions and healthcare encounters related to the digital therapeutic, measured using electronic health record data. Univariate statistics were calculated for cost estimates with comparisons presented by trial arm, implementation activity, staff role and study month. Analyses were conducted from a health system perspective. Twenty-one primary care sites participated in the trial. Over the 50-month study period, the total cost of all implementation activities was $748,088. Implementation costs per clinic were highest in the SI + PF + HC arm ($48,029), followed by SI + HC ($36,544), SI + PF ($30,665) and SI alone ($24,774). Intervention costs were highest in the SI + PF + HC arm ($18,051), followed by SI + PF ($11,492), SI + HC ($967) and SI alone ($1,879). Findings from this study can guide health systems by informing the economic investment required to employ implementation strategies demonstrated to increase uptake of evidence-based practices for behavioral health conditions. Trial Registration: NCT05160233.

Identifiers

PMID41505485
PMCPMC12782369

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.